To direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. American Made Pharmaceuticals Act of 2022. S. 3991. 117th
Cong., 2nd
sess., Introduced in Senate April 5, 2022. https://www.govinfo.gov/app/details/BILLS-117s3991is.
APA
Congress, Senate (2022, April 5). American Made Pharmaceuticals Act of 2022 (S. 3991 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-117s3991is.
MLA
United States, Congress, Senate. American Made Pharmaceuticals Act of 2022. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-117s3991is. 117th Congress, S. 3991, Introduced in Senate 5 Apr. 2022.
Bluebook
S.3991 - 117th Congress (2021-2022): American Made Pharmaceuticals Act of 2022, S.3991, 117th Cong. (2022), https://www.govinfo.gov/app/details/BILLS-117s3991is.
